Epclusa
Epclusa is a medicine authorised by Swissmedic under authorisation number 66095. The authorisation holder is Gilead Sciences Switzerland Sàrl. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 22 September 2016 and the authorisation is valid without a time limit. ATC code J05AP55 places the medicine in the group Antivirals for systemic use.
| Authorisation number | 66095 |
|---|---|
| Name | Epclusa |
| Full name | Epclusa, Filmtabletten |
| Authorisation holder | Gilead Sciences Switzerland Sàrl |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | J05AP55 |
| First authorisation | 22 September 2016 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Epclusa, Filmtabletten | A | 22 September 2016 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 28 | Tablette(n) | J05AP55 | 08.03.0. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Epclusa authorised in Switzerland?
Yes. Epclusa is authorised by Swissmedic under authorisation number 66095, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Epclusa have?
Epclusa is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Epclusa?
The authorisation holder is Gilead Sciences Switzerland Sàrl. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.